BioResearch
Diluted Smallpox Vaccine Stretches Supply
Results from a key clinical trial indicate that the 15.4 million doses in the existing U.S. supply of smallpox vaccine could successfully be diluted up to five times and retain its potency, effectively expanding the number of individuals it could protect from the contagious disease. More...23 May 2002
In Other News
Genetic Basis Found for Septic Shock
Gene Reactivation May Inhibit Stomach Cancer
Researchers Trace Origins of Superbugs
Chemotherapy May Paradoxically Trigger Future Cancer
New Image of Dengue Virus Revealed
Master Gene Found for Intellectual Disability and Epilepsy
Molecular Insights into Angiogenic Protein
Nuclear Transplantation Corrects Immune Deficiency
Microarrays Yield Insights on Breast Cancer Genes
Alliance for the Development of Novel Cancer Drugs
Alliance for the Development of Novel Cancer Drugs
Alliance for Processing Protein Microarrays
New Way to Externally View Growing Tumor Cells
Retinoic Acid Triggers Cancer-Killing Gene
Johnson & Johnson to Acquire Tibotec-Virco
New High-Speed Sequencing Technology
Protein Directs Neural Stem Cell Migration
Breakthrough in Vaccines for Autoimmune Disorders
Genetic Variation Increases Hypertension Risk
Freeze-Drying Blood Platelets for Long-Term Storage
MicroRNAs Linked to Neurodegenerative Disease
Gene for Drug Abuse Identified
Oxygen-Generated Free Radicals Damage Chromosomes
BioResearch brings the latest research news on the genome, proteome, metabolome, on drug discovery, and therapeutics. Biotech researchers, lab administrators, technologists, drug manufacturers, and suppliers can find the latest research news and information related to their fields of endeavor here.







